224 related articles for article (PubMed ID: 23845841)
1. Predictors of postoperative complications after trimodality therapy for esophageal cancer.
Wang J; Wei C; Tucker SL; Myles B; Palmer M; Hofstetter WL; Swisher SG; Ajani JA; Cox JD; Komaki R; Liao Z; Lin SH
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):885-91. PubMed ID: 23845841
[TBL] [Abstract][Full Text] [Related]
2. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
[TBL] [Abstract][Full Text] [Related]
3. A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients.
Lester SC; Lin SH; Chuong M; Bhooshan N; Liao Z; Arnett AL; James SE; Evans JD; Spears GM; Komaki R; Haddock MG; Mehta MP; Hallemeier CL; Merrell KW
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):820-828. PubMed ID: 28476435
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma.
Gerber N; Ilson DH; Wu AJ; Janjigian YY; Kelsen DP; Zheng J; Zhang Z; Bains MS; Rizk N; Rusch VW; Goodman KA
Dis Esophagus; 2014 Apr; 27(3):235-41. PubMed ID: 23796070
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgery.
Cho WK; Oh D; Kim HK; Ahn YC; Noh JM; Shim YM; Zo JI; Choi YS; Sun JM; Lee SH; Ahn MJ; Park K; Nam H
Radiother Oncol; 2019 Apr; 133():87-92. PubMed ID: 30935586
[TBL] [Abstract][Full Text] [Related]
7. Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer.
Lin SH; Merrell KW; Shen J; Verma V; Correa AM; Wang L; Thall PF; Bhooshan N; James SE; Haddock MG; Suntharalingam M; Mehta MP; Liao Z; Cox JD; Komaki R; Mehran RJ; Chuong MD; Hallemeier CL
Radiother Oncol; 2017 Jun; 123(3):376-381. PubMed ID: 28455153
[TBL] [Abstract][Full Text] [Related]
8. Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting.
Murphy CC; Hofstetter WL; Correa AM; Ajani JA; Komaki RU; Swisher SG
Dis Esophagus; 2013; 26(7):708-15. PubMed ID: 23350713
[TBL] [Abstract][Full Text] [Related]
9. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
Wang SL; Liao Z; Vaporciyan AA; Tucker SL; Liu H; Wei X; Swisher S; Ajani JA; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):692-9. PubMed ID: 16242257
[TBL] [Abstract][Full Text] [Related]
10. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer.
Hayashi Y; Xiao L; Suzuki A; Blum MA; Sabloff B; Taketa T; Maru DM; Welsh J; Lin SH; Weston B; Lee JH; Bhutani MS; Hofstetter WL; Swisher SG; Ajani JA
Eur J Cancer; 2012 Dec; 48(18):3396-404. PubMed ID: 22853875
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725
[TBL] [Abstract][Full Text] [Related]
12. Influence of preoperative radiation field on postoperative leak rates in esophageal cancer patients after trimodality therapy.
Juloori A; Tucker SL; Komaki R; Liao Z; Correa AM; Swisher SG; Hofstetter WL; Lin SH
J Thorac Oncol; 2014 Apr; 9(4):534-40. PubMed ID: 24736077
[TBL] [Abstract][Full Text] [Related]
13. Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer.
Shaikh T; Churilla TM; Monpara P; Scott WJ; Cohen SJ; Meyer JE
Pract Radiat Oncol; 2016; 6(6):388-394. PubMed ID: 27025161
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy at high-volume centers improves survival in patients with esophageal adenocarcinoma receiving trimodality therapy.
Yang GQ; Mhaskar R; Rishi A; Naghavi AO; Frakes JM; Almhanna K; Fontaine J; Pimiento JM; Hoffe SE
Dis Esophagus; 2019 Aug; 32(8):. PubMed ID: 30597022
[TBL] [Abstract][Full Text] [Related]
15. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters.
Lee HK; Vaporciyan AA; Cox JD; Tucker SL; Putnam JB; Ajani JA; Liao Z; Swisher SG; Roth JA; Smythe WR; Walsh GL; Mohan R; Liu HH; Mooring D; Komaki R
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1317-22. PubMed ID: 14630268
[TBL] [Abstract][Full Text] [Related]
16. Tolerance and efficacy of dose escalation using IMRT combined with chemotherapy for unresectable esophageal carcinoma: Long-term results of 51 patients.
Modesto A; Dalmasso C; Lusque A; Vieillevigne L; Izar F; Moyal E; Carrère N; Guimbaud R; Rives M
Cancer Radiother; 2020 Apr; 24(2):88-92. PubMed ID: 32156457
[TBL] [Abstract][Full Text] [Related]
17. Dose escalated neoadjuvant chemoradiotherapy with dose-painting intensity-modulated radiation therapy and improved pathologic complete response in locally advanced esophageal cancer.
Venkat PS; Shridhar R; Naghavi AO; Hoffe SE; Almhanna K; Pimiento JM; Fontaine JP; Abuodeh Y; Meredith KL; Frakes JM
Dis Esophagus; 2017 Jul; 30(7):1-9. PubMed ID: 30052899
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Intensity-Modulated Radiation Therapy (IMRT), Proton and 3D Conformal Radiotherapy (3D-CRT) for Reducing Perioperative Cardiopulmonary Complications in Esophageal Cancer Patients.
Ling TC; Slater JM; Nookala P; Mifflin R; Grove R; Ly AM; Patyal B; Slater JD; Yang GY
Cancers (Basel); 2014 Dec; 6(4):2356-68. PubMed ID: 25489937
[TBL] [Abstract][Full Text] [Related]
19. Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.
Lin SH; Wang L; Myles B; Thall PF; Hofstetter WL; Swisher SG; Ajani JA; Cox JD; Komaki R; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1078-85. PubMed ID: 22867894
[TBL] [Abstract][Full Text] [Related]
20. Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancer.
Shaikh T; Thomay A; Ruth K; Cohen SJ; Meyer JE
J Surg Oncol; 2015 Nov; 112(6):629-33. PubMed ID: 26430952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
